Cengild Medical Berhad (0243) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.008x

Based on the latest financial reports, Cengild Medical Berhad (0243) has a cash flow conversion efficiency ratio of 0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM947.00K ≈ $237.76K USD) by net assets (RM116.98 Million ≈ $29.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Cengild Medical Berhad (0243) strategic investment index to assess the company's strategic physical and investment asset allocation.

Cengild Medical Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Cengild Medical Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 0243 net assets for net asset value and shareholders' equity analysis.

Cengild Medical Berhad Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cengild Medical Berhad ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Fuel Tech Inc
NASDAQ:FTEK
-0.022x
Unibios Holdings S.A
AT:BIOSK
0.021x
Baltic Sea Properties AS
OL:BALT
0.027x
NexLiving Communities Inc
V:NXLV
0.062x
Full Wang International Development Co Ltd
TWO:6219
-0.287x
PB Bankshares Inc
NASDAQ:PBBK
0.015x
Guler Yatirim Holding AS
IS:GLRYH
0.065x
Freja eID Group AB
ST:FREJA
0.075x

Annual Cash Flow Conversion Efficiency for Cengild Medical Berhad (2020–2025)

The table below shows the annual cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see 0243 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 RM114.46 Million
≈ $28.74 Million
RM16.08 Million
≈ $4.04 Million
0.140x +20.87%
2024-06-30 RM111.30 Million
≈ $27.94 Million
RM12.94 Million
≈ $3.25 Million
0.116x -10.39%
2023-06-30 RM106.11 Million
≈ $26.64 Million
RM13.76 Million
≈ $3.46 Million
0.130x -14.22%
2022-06-30 RM92.95 Million
≈ $23.34 Million
RM14.05 Million
≈ $3.53 Million
0.151x -85.43%
2021-06-30 RM13.78 Million
≈ $3.46 Million
RM14.30 Million
≈ $3.59 Million
1.038x -9.62%
2020-06-30 RM9.79 Million
≈ $2.46 Million
RM11.24 Million
≈ $2.82 Million
1.148x --

About Cengild Medical Berhad

KLSE:0243 Malaysia Medical Care Facilities
Market Cap
$47.05 Million
RM187.41 Million MYR
Market Cap Rank
#22242 Global
#498 in Malaysia
Share Price
RM0.23
Change (1 day)
+0.00%
52-Week Range
RM0.20 - RM0.26
All Time High
RM0.55
About

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more